Publications by authors named "Julie Quick"
Evidence-based practice: The cornerstone of clinical decision making.
J Perioper Pract
December 2022
Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
December 2022
Background: Triple-class relapsed/refractory multiple myeloma (RRMM) has a poor prognosis. This study analyzed the clinical outcomes of Belantamab mafadotin in combination with dexamethasone (Bd) in triple-class RRMM.
Methods: We identified 35 patients with triple-class RRMM who received Bd at the University of Kansas from October 2019 to November 2021.